International Medical Center of Biomaterials Processing and Cryostorage (MOEX:GEMA)

Russia · Delayed Price · Currency is RUB

672.00

-1.50 (-0.22%)

At close: Jul 8, 2022

MOEX:GEMA Income Statement

Financials in millions RUB. Fiscal year is January - December.

Millions RUB. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	367.7	348.6	283.51	254.68	265.89	242.63
Revenue Growth (YoY)	18.95%	22.96%	11.32%	-4.22%	9.59%	1.69%
Cost of Revenue	67.62	58.72	47.95	51.67	61.82	30.87
Gross Profit	300.08	289.89	235.56	203	204.07	211.76
Selling, General & Admin	118.77	111.74	86.2	64.41	65.52	53.69
Amortization of Goodwill & Intangibles	-	-	-	-	-	2.1
Other Operating Expenses	-	-	-	-	-	5.81
Operating Expenses	118.77	111.74	86.2	64.41	66.17	69.9
Operating Income	181.31	178.15	149.36	138.6	137.9	141.86
Interest Expense	-34.77	-34.57	-33.56	-17.62	-3.52	-6.84
Interest & Investment Income	29.05	23.85	11.98	10.54	17.48	2.24
Earnings From Equity Investments	-	9	6.53	-	-	-
Currency Exchange Gain (Loss)	-0.03	-	-	-	-	-0.09
Other Non Operating Income (Expenses)	-21.65	-21.93	-8.73	-32	-18.7	-14.39
EBT Excluding Unusual Items	153.91	154.51	125.58	99.52	133.17	122.77
Gain (Loss) on Sale of Assets	-3.29	-3.29	0.2	-1.35	-4	-
Pretax Income	151.14	151.22	125.78	98.17	129.17	122.77
Net Income	151.14	151.22	125.78	98.17	129.17	122.77
Preferred Dividends & Other Adjustments	-	-	-	-	-21.57	-
Net Income to Common	151.14	151.22	125.78	98.17	150.74	122.77
Net Income Growth	5.83%	20.22%	28.13%	-24.00%	5.21%	2.95%
Shares Outstanding (Basic)	15	15	15	15	15	15
Shares Outstanding (Diluted)	15	15	15	15	15	15
Shares Change (YoY)	-0.05%	-	-	-0.00%	0.00%	11.11%
EPS (Basic)	10.13	10.13	8.42	6.58	10.10	8.22
EPS (Diluted)	10.13	10.13	8.42	6.58	10.10	8.22
EPS Growth	5.88%	20.22%	28.13%	-34.88%	22.79%	-7.35%
Free Cash Flow	246.28	237.02	209.59	231.83	239.82	132.26
Free Cash Flow Per Share	16.50	15.88	14.04	15.53	16.06	8.86
Dividend Per Share	7.700	7.700	6.420	8.022	8.650	-
Dividend Growth	246.85%	19.94%	-19.97%	-7.26%	-	-
Gross Margin	81.61%	83.16%	83.09%	79.71%	76.75%	87.28%
Operating Margin	49.31%	51.10%	52.68%	54.42%	51.86%	58.47%
Profit Margin	41.10%	43.38%	44.37%	38.55%	56.69%	50.60%
Free Cash Flow Margin	66.98%	67.99%	73.93%	91.03%	90.20%	54.51%
EBITDA	190.81	187.01	157.64	142.41	142.04	148.31
EBITDA Margin	51.89%	53.64%	55.60%	55.92%	53.42%	61.13%
D&A For EBITDA	9.5	8.86	8.28	3.81	4.14	6.45
EBIT	181.31	178.15	149.36	138.6	137.9	141.86
EBIT Margin	49.31%	51.10%	52.68%	54.42%	51.86%	58.47%
Revenue as Reported	-	-	-	-	-	242.63
Advertising Expenses	-	28.32	23.97	17.11	15.86	8.17

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.